Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D K Granger

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Transplantation|June 1, 1994
Steroid-related complications in the cyclosporine eraJ P Fryer, D K Granger, J R Leventhal, et al.
Surgery|August 1, 1994
Prolonged survival without posttransplant immunosuppression in a large animal modelD K Granger, A J Matas, M K Jenkins, et al.
Transplantation Proceedings|October 1, 1994
Cyclosporine levels impact early rejection episodesD K Granger, N B Amin, A L Sorenson, et al.
Transplantation Proceedings|March 20, 1999
Vascular graft thrombosis after pancreas transplantation: comparison of the FK 506 and cyclosporine erasR Kandaswamy, A Humar, A C Gruessner, et al.
Transplantation Proceedings|October 1, 1994
Effects of ketoconazole on cyclosporine metabolism in renal allograft recipientsA L Sorenson, M Lovdahl, J M Hewitt, et al.
Transplantation|January 27, 1995
Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapyD K Granger, J W Cromwell, S C Chen, et al.
Transplantation Proceedings|June 20, 2002
Donor/recipient skin and whole-blood cyclosporin A levels in a swine composite tissue allograft model: correlation and relationship to rejectionJ Edelstein, J W Jones, X Ren, et al.
Transplantation Proceedings|April 1, 1996
A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipientsE M Johnson, J Zimmerman, K Duderstadt, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Transplantation|June 1, 1994
Steroid-related complications in the cyclosporine eraJ P Fryer, D K Granger, J R Leventhal, et al.
Surgery|August 1, 1994
Prolonged survival without posttransplant immunosuppression in a large animal modelD K Granger, A J Matas, M K Jenkins, et al.
Transplantation Proceedings|October 1, 1994
Cyclosporine levels impact early rejection episodesD K Granger, N B Amin, A L Sorenson, et al.
Transplantation Proceedings|March 20, 1999
Vascular graft thrombosis after pancreas transplantation: comparison of the FK 506 and cyclosporine erasR Kandaswamy, A Humar, A C Gruessner, et al.
Transplantation Proceedings|October 1, 1994
Effects of ketoconazole on cyclosporine metabolism in renal allograft recipientsA L Sorenson, M Lovdahl, J M Hewitt, et al.
Transplantation|January 27, 1995
Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapyD K Granger, J W Cromwell, S C Chen, et al.
Transplantation Proceedings|June 20, 2002
Donor/recipient skin and whole-blood cyclosporin A levels in a swine composite tissue allograft model: correlation and relationship to rejectionJ Edelstein, J W Jones, X Ren, et al.
Transplantation Proceedings|April 1, 1996
A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipientsE M Johnson, J Zimmerman, K Duderstadt, et al.
Pageof 2